Brokerages Set Pediatrix Medical Group, Inc. (NYSE:MD) Target Price at $9.38

Shares of Pediatrix Medical Group, Inc. (NYSE:MD) have earned an average rating of “Hold” from the four analysts that are presently covering the firm, MarketBeat.com reports. Four research analysts have rated the stock with a hold rating. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $9.38.

MD has been the subject of a number of research reports. Jefferies Financial Group dropped their price target on Pediatrix Medical Group from $10.00 to $9.00 and set a “hold” rating for the company in a research note on Wednesday, March 6th. Truist Financial reaffirmed a “hold” rating and issued a $10.00 price objective on shares of Pediatrix Medical Group in a research note on Wednesday, May 15th. Mizuho lowered their price objective on Pediatrix Medical Group from $10.00 to $9.00 and set a “neutral” rating for the company in a research note on Wednesday, February 21st. Finally, TheStreet lowered Pediatrix Medical Group from a “c” rating to a “d” rating in a research note on Friday, February 23rd.

Institutional Investors Weigh In On Pediatrix Medical Group

Institutional investors and hedge funds have recently modified their holdings of the business. Performa Ltd US LLC lifted its stake in shares of Pediatrix Medical Group by 130.8% during the 4th quarter. Performa Ltd US LLC now owns 3,000 shares of the company’s stock worth $28,000 after acquiring an additional 1,700 shares during the last quarter. Counterpoint Mutual Funds LLC lifted its stake in shares of Pediatrix Medical Group by 53.4% during the 4th quarter. Counterpoint Mutual Funds LLC now owns 10,140 shares of the company’s stock worth $94,000 after acquiring an additional 3,528 shares during the last quarter. AXQ Capital LP bought a new stake in shares of Pediatrix Medical Group during the 3rd quarter worth approximately $135,000. Virtu Financial LLC bought a new stake in shares of Pediatrix Medical Group during the 1st quarter worth approximately $124,000. Finally, TD Asset Management Inc bought a new stake in shares of Pediatrix Medical Group during the 3rd quarter worth approximately $167,000. 97.71% of the stock is owned by institutional investors.

Pediatrix Medical Group Price Performance

Shares of Pediatrix Medical Group stock opened at $7.46 on Monday. The stock has a 50 day moving average of $8.95 and a 200 day moving average of $9.12. Pediatrix Medical Group has a 12 month low of $7.26 and a 12 month high of $15.02. The firm has a market cap of $627.76 million, a PE ratio of -8.78, a PEG ratio of 1.42 and a beta of 1.58. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.81.

Pediatrix Medical Group (NYSE:MD) last announced its quarterly earnings results on Tuesday, May 7th. The company reported $0.17 EPS for the quarter, beating analysts’ consensus estimates of $0.15 by $0.02. Pediatrix Medical Group had a positive return on equity of 10.31% and a negative net margin of 3.53%. The company had revenue of $495.10 million during the quarter, compared to analyst estimates of $496.25 million. On average, research analysts expect that Pediatrix Medical Group will post 1.12 EPS for the current fiscal year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.